Reddys Laboratories launches generic version of fesoterodine fumarate tablets in US

The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022 Dr Reddys Said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market. The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing. The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!